Experienced in Alpha Thalassemia

Overview

William Ferguson is a Pediatric Hematologist Oncology specialist and a Hematologist in Saint Louis, Missouri. Dr. Ferguson and is rated as an Experienced provider by MediFind in the treatment of Alpha Thalassemia. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Medulloblastoma, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 27 peer reviewed articles and participating in 50 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Alpha Thalassemia.

Specialties
Pediatric Hematology Oncology
Hematology
Oncology
Licenses
Pediatric Hematology-Oncology in MO
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Oscar
  •  Humana

Locations

1465 S Grand Blvd, Saint Louis, MO 63104
314-577-5638

Additional Areas of Focus

Dr. Ferguson has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


50 Clinical Trials

A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
A Phase II Trial of Nifurtimox for Refractory or Relapsed Neuroblastoma or Medulloblastoma.
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
View 48 Less Clinical Trials
Similar Doctors
Expertise in
26
conditions
Oncology | Hematology
Expertise in
26
conditions
Oncology | Hematology

Van Amburg And Busiek Mds LLC

232 S Woods Mill Rd, Suite 330e, 
Chesterfield, MO 
 (14.5 mi)
Languages Spoken:
English
Accepting New Patients

Elliot Abbey is an Oncologist and a Hematologist in Chesterfield, Missouri. Dr. Abbey and is rated as a Distinguished provider by MediFind in the treatment of Alpha Thalassemia. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Anemia, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Abbey is currently accepting new patients.

Expertise in
37
conditions
Hematology Oncology | Oncology | Hematology
Expertise in
37
conditions
Hematology Oncology | Oncology | Hematology

Mercy Clinic Specialists Services-Illinois LLC

2227 Vadalabene Dr, Suite 200, 
Maryville, IL 
 (17.8 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Syed Arshad is a Hematologist Oncology specialist and an Oncologist in Maryville, Illinois. Dr. Arshad and is rated as a Distinguished provider by MediFind in the treatment of Alpha Thalassemia. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Drug-Induced Thrombocytopenia, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Arshad is currently accepting new patients.

Expertise in
2
conditions
Oncology | Hospital Medicine | Hematology
Expertise in
2
conditions
Oncology | Hospital Medicine | Hematology

Washington University

1 Barnes Jew Hosp Plz, 
Saint Louis, MO 
 (1.7 mi)
Experience:
12+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Kelly Bolton is an Oncologist and a Hospital Medicine provider in Saint Louis, Missouri. Dr. Bolton has been practicing medicine for over 12 years and is rated as an Experienced provider by MediFind in the treatment of Alpha Thalassemia. Her top areas of expertise are Ovarian Cancer, Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Bolton is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile